Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryka Quik

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Journal of Neurochemistry|February 5, 2013
The nicotine-mediated decline in l-dopa-induced dyskinesias is associated with a decrease in striatal dopamine releaseTanuja Bordia, J Michael McIntosh, Maryka Quik
Trends in Pharmacological Sciences|April 7, 2007
Nicotine neuroprotection against nigrostriatal damage: importance of the animal modelMaryka Quik, Michael O'Neill, Xiomara A Perez
The Journal of Pharmacology and Experimental Therapeutics|December 7, 2011
Nicotine reduces antipsychotic-induced orofacial dyskinesia in ratsTanuja Bordia, J Michael McIntosh, Maryka Quik
Biochemical Pharmacology|June 21, 2015
Alpha7 nicotinic receptors as therapeutic targets for Parkinson's diseaseMaryka Quik, Danhui Zhang, Matthew McGregor, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 14, 2011
Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptorsLuping Z Huang, Sharon R Grady, Maryka Quik
Biochemical Pharmacology|June 21, 2011
Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disordersMaryka Quik, Xiomara A Perez, Sharon R Grady
Movement Disorders : Official Journal of the Movement Disorder Society|July 10, 2013
Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's diseaseMaryka Quik, Archana Mallela, Jason Ly, et al.
Journal of Psychiatry & Neuroscience : JPN|April 24, 2015
Obituary of Theodore L. Sourkes, PhD, FRSC, OCSimon Young, Maryka Quik, Guillermina Almazan, et al.
Molecular Pharmacology|December 26, 2001
Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sitesJennifer M Kulak, J Michael McIntosh, Maryka Quik
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2008
Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's diseaseTanuja Bordia, Carla Campos, Luping Huang, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Journal of Neurochemistry|February 5, 2013
The nicotine-mediated decline in l-dopa-induced dyskinesias is associated with a decrease in striatal dopamine releaseTanuja Bordia, J Michael McIntosh, Maryka Quik
Trends in Pharmacological Sciences|April 7, 2007
Nicotine neuroprotection against nigrostriatal damage: importance of the animal modelMaryka Quik, Michael O'Neill, Xiomara A Perez
The Journal of Pharmacology and Experimental Therapeutics|December 7, 2011
Nicotine reduces antipsychotic-induced orofacial dyskinesia in ratsTanuja Bordia, J Michael McIntosh, Maryka Quik
Biochemical Pharmacology|June 21, 2015
Alpha7 nicotinic receptors as therapeutic targets for Parkinson's diseaseMaryka Quik, Danhui Zhang, Matthew McGregor, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 14, 2011
Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptorsLuping Z Huang, Sharon R Grady, Maryka Quik
Biochemical Pharmacology|June 21, 2011
Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disordersMaryka Quik, Xiomara A Perez, Sharon R Grady
Movement Disorders : Official Journal of the Movement Disorder Society|July 10, 2013
Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's diseaseMaryka Quik, Archana Mallela, Jason Ly, et al.
Journal of Psychiatry & Neuroscience : JPN|April 24, 2015
Obituary of Theodore L. Sourkes, PhD, FRSC, OCSimon Young, Maryka Quik, Guillermina Almazan, et al.
Molecular Pharmacology|December 26, 2001
Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sitesJennifer M Kulak, J Michael McIntosh, Maryka Quik
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2008
Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's diseaseTanuja Bordia, Carla Campos, Luping Huang, et al.
Pageof 8